Research Institute For Personalized Medicine In is categorized under Health Services in Boca Raton, FL and active since 2009.
Research Institute For Personalized Medicine In was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Seth J Baum at the company’s single location by writing to 2300 Glades Road # 100e, Boca Raton, Florida FL 33431 or by phoning (561) 392-8017. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Research Institute For Personalized Medicine In |
Contact Person: | Seth J Baum |
Address: | 2300 Glades Road # 100e, Boca Raton, Florida 33431 |
Phone Number: | (561) 392-8017 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Services |
SIC Code: | 8099 |
NAICS Code: | 621999 |
Share This Business: |
Research Institute For Personalized Medicine In was started in 2009 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Seth J Baum for inquiries that concern Research Institute For Personalized Medicine In by calling the company number (561) 392-8017, as your correspondence is most welcome. Additionally, the physical location of the single location of Research Institute For Personalized Medicine In can be found at the coordinates 26.368023,-80.128767 as well as the street address 2300 Glades Road # 100e in Boca Raton, Florida 33431.
For its online presence, you may visit Research Institute For Personalized Medicine In’s website at and engage with its social media outlets through on Twitter and on Facebook.